Jazz Pharmaceuticals(JAZZ) Stock Price Today | Quotes & News - Moomoo

US Stock MarketDetailed Quotes

JAZZ Jazz Pharmaceuticals

Watchlist

120.050
+2.870+2.45%

Close May 2 16:00 ET

120.050
0.0000.00%

Post 16:05 ET

7.40BMarket Cap13.88P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Is Jazz Pharmaceuticals (NASDAQ:JAZZ) A Risky Investment?
Simply Wall StMay 2 06:24 ET
Earnings Preview: JAZZ to Report Financial Results Post-market on May 06
Moomoo NewsApr 30 21:00 ET
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference
PR NewswireApr 30 16:15 ET
With A 14% Return On Equity, Is Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) A Quality Stock?
Yahoo FinanceApr 29 07:00 ET
RBC Capital Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $182
Moomoo NewsApr 29 02:44 ET · Ratings
Jazz Pharmaceuticals (JAZZ) Gets a Buy From RBC Capital
TipRanksApr 28 06:58 ET · Ratings

Comments

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

$Jazz Pharmaceuticals (JAZZ.US)$
Breakthrough: EU Panel Endorses First-Ever HER2 Treatment for Rare Biliary Cancer - What This Means for Patients

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse

$Jazz Pharmaceuticals (JAZZ.US)$
Major Cancer Breakthrough: New Phase 3 Data Reveals Significant Survival Benefits in Lung Cancer Treatment

Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse

$Jazz Pharmaceuticals (JAZZ.US)$ What happened with this stock? Why did it go down so much?

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

$Jazz Pharmaceuticals (JAZZ.US)$ $Chimerix(Delisted) (CMRX.US)$
Can Jazz's $935M Chimerix Acquisition Transform Rare Brain Tumor Treatment? FDA Decision Looms

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

1

$Jazz Pharmaceuticals (JAZZ.US)$ just so you all know that this and $Sarepta Therapeutics (SRPT.US)$ are in the same area as $Cumberland Pharmaceuticals (CPIX.US)$ if you wanna know where CPIX price will be in the future

1

Read more